A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed/refractory multiple myeloma: the CLARITY study protocol

BACKGROUND: Treatment decision-making in patients with relapsed/refractory multiple myeloma (RRMM) is challenging for a number of reasons including, the heterogeneity of disease at relapse and the number of possible therapeutic approaches. This study broadly aims to generate new evidence-based data...

Descripción completa

Detalles Bibliográficos
Autores principales: Efficace, Fabio, Boccadoro, Mario, Palumbo, Antonio, Petrucci, Maria Teresa, Cottone, Francesco, Cannella, Laura, Zamagni, Elena, Niscola, Pasquale, Kyriakou, Charalampia, Caravita, Tommaso, Offidani, Massimo, Mandelli, Franco, Cavo, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006751/
https://www.ncbi.nlm.nih.gov/pubmed/29914509
http://dx.doi.org/10.1186/s12955-018-0953-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006751/
https://www.ncbi.nlm.nih.gov/pubmed/29914509
http://dx.doi.org/10.1186/s12955-018-0953-4

Ejemplares similares